TrialNeuro-oncology2014

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.

Patrick Y Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.